Bio2 Technologies wins FDA nod for bioactive bone scaffolds

The FDA grants 510(k) clearance for Bio2 Technologies' CLM bioactive scaffold wedges.

Massachusetts startup Bio2 Technologies plans a limited rollout in 2015 of its high-tech bioactive bone scaffold wedges, following the FDA's recent 510(k) clearance of the product.

Bio2 Technologies, Food & Drug Administration (FDA)

News Well, 510(k), Orthopedics, Regenerative Medicine, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Ce3AIK